- Home
- ROIV vs TTEK Comparison
ROIV vs TTEK Comparison
Compare ROIV & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- TTEK
- Stock Information
- Founded
- ROIV 2014
- TTEK 1966
- Country
- ROIV United Kingdom
- TTEK United States
- Employees
- ROIV N/A
- TTEK N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- TTEK Military/Government/Technical
- Sector
- ROIV Health Care
- TTEK Consumer Discretionary
- Exchange
- ROIV Nasdaq
- TTEK Nasdaq
- Market Cap
- ROIV 8.6B
- TTEK 9.4B
- IPO Year
- ROIV N/A
- TTEK 1991
- Fundamental
- Price
- ROIV $14.08
- TTEK $36.14
- Analyst Decision
- ROIV Strong Buy
- TTEK Buy
- Analyst Count
- ROIV 4
- TTEK 5
- Target Price
- ROIV $15.50
- TTEK $42.25
- AVG Volume (30 Days)
- ROIV 6.6M
- TTEK 2.0M
- Earning Date
- ROIV 11-11-2025
- TTEK 11-12-2025
- Dividend Yield
- ROIV N/A
- TTEK 0.72%
- EPS Growth
- ROIV N/A
- TTEK N/A
- EPS
- ROIV N/A
- TTEK 0.80
- Revenue
- ROIV $23,233,000.00
- TTEK $4,598,536,000.00
- Revenue This Year
- ROIV N/A
- TTEK $6.67
- Revenue Next Year
- ROIV $281.14
- TTEK N/A
- P/E Ratio
- ROIV N/A
- TTEK $45.08
- Revenue Growth
- ROIV N/A
- TTEK 8.59
- 52 Week Low
- ROIV $8.73
- TTEK $27.27
- 52 Week High
- ROIV $14.48
- TTEK $51.20
- Technical
- Relative Strength Index (RSI)
- ROIV 76.40
- TTEK 48.94
- Support Level
- ROIV $11.85
- TTEK $34.67
- Resistance Level
- ROIV $14.48
- TTEK $36.28
- Average True Range (ATR)
- ROIV 0.42
- TTEK 0.74
- MACD
- ROIV 0.21
- TTEK -0.01
- Stochastic Oscillator
- ROIV 86.26
- TTEK 58.80
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About TTEK Tetra Tech Inc.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.